Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Corporate Governance
2019.12.03
《公司章程》修订对照表
2019.12.03
股东大会议事规则（2019年12月）
2019.12.03
独立董事关于第四届董事会第二十六次会议相关事项的事前认可意见
2019.12.03
独立董事关于第四届董事会第二十六次会议相关事项的独立意见
2019.12.03
重大投资决策管理制度（2019年12月）
2019.12.03
董事会议事规则（2019年12月）
2019.12.03
监事会议事规则（2019年12月）
2019.12.03
对外担保管理制度（2019年12月）
2019.12.03
独立董事工作制度（2019年12月）
2019.12.03
关联交易决策制度（2019年12月）
第一页
上一页
5
6
7
8
9
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
